Abstract
It is very important for us to first recognize the successes we are having in the treatment of metastatic colorectal cancer. With novel chemotherapies, biological therapies, surgical interventions and liver-directed therapies, we have nearly tripled the survival of patients with this common deadly disease. But unfortunately healthcare delivery around the world is very expensive and very complicated and therefore only accessible to those with the highest level of means and access. We have in essence created medical care on the luxury level. In this perspective piece, we will review how we got here and some ideas of how we can go forward, making room for innovations to come.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
